Safety evaluation of intravenous immunoglobulin in pediatric patients: a retrospective, 1-year observational study.

Reem ElajezAsmaa EzzeldinHossamaldein Gaber

Published in: Therapeutic advances in drug safety (2019)

IVIG generally has a good safety profile in pediatric patients, with low risk of severe ADR. More studies are needed to evaluate the correlation between ADR and IVIG formulation, taking into account other factors that may affect results.

Keyphrases

adverse drug
high dose
early onset